Answers are grounded in this paper and cite their sources.
There was no significant correlation between serum sPD-L1 concentration and tissue PD-L1 expression level. sPD-L1 concentration before treatment could be an effective and convenient biomarker of prognosis in patients with locally advanced or metastatic ESCC treated with combination cytotoxic chemotherapy.
No takes yet. Share an insight, caveat, or question.
Fu et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: